Biotech - Drug Development

Biotechnology companies developing novel therapeutics across disease areas (excluding oncology-focused)
TickerCompanySub-ThemeMkt CapPriceChg%Volume
LLYLLYEli Lilly & Co.
Metabolic & Cardiometabolic
$1.0t$1169.34+3.4%1.5M
JNJJNJJohnson & Johnson
Immunology & Autoimmune
$0.5t$232.12-0.3%1.5M
ABBVABBVABBVIE INC.
Immunology & Autoimmune
$384.7b$224.26-1.3%1.2M
MRKMRKMerck & Co., Inc.
Infectious Disease & Vaccines
$293.2b$120.91+0.1%2.3M
AZNAZNAstraZeneca PLC
Metabolic & Cardiometabolic
$287.9b$183.90-1.1%630.7K
TMOTMOThermo Fisher Scientific, Inc.
Clinical-Stage Platforms
$183.0b$474.47+0.4%345.4K
AMGNAMGNAmgen Inc
Immunology & AutoimmuneRare Disease Therapeutics
$181.8b$346.84-0.8%440.9K
GILDGILDGilead Sciences Inc
Infectious Disease & Vaccines
$166.9b$128.72-0.3%1.4M
PFEPFEPfizer Inc.
Infectious Disease & Vaccines
$149.2b$25.96-0.3%10.0M
BMYBMYBristol-Myers Squibb Co.
Immunology & Autoimmune
$116.8b$56.84-0.7%2.5M
VRTXVRTXVertex Pharmaceuticals Inc
Rare Disease Therapeutics
$113.6b$447.55+0.2%219.4K
REGNREGNRegeneron Pharmaceuticals Inc
Immunology & Autoimmune
$64.5b$623.11-1.9%125.9K
ALNYALNYAlnylam Pharmaceuticals, Inc.
Rare Disease Therapeutics
$40.3b$288.42-4.8%479.1K
AAAgilent Technologies Inc.
Clinical-Stage Platforms
$38.2b$135.37-0.0%228.8K
WATWATWaters Corp
Clinical-Stage Platforms
$37.7b$368.49+0.9%114.5K
IQVIQVIQVIA Holdings Inc.
Clinical-Stage Platforms
$30.4b$184.25+0.4%148.1K
BIIBBIIBBiogen Inc. Common Stock
Neuroscience & CNS
$28.9b$195.58+0.1%241.7K
RPRXRPRXRoyalty Pharma plc Class A Ordinary Shares
Clinical-Stage Platforms
$24.7b$55.84-0.1%990.5K
UTHRUTHRUnited Therapeutics Corp
Rare Disease Therapeutics
$23.6b$552.23+0.4%85.7K
INSMINSMInsmed, Inc.
Rare Disease Therapeutics
$23.2b$96.09+2.0%1.3M
WSTWSTWest Pharmaceutical Services, Inc.
Clinical-Stage Platforms
$22.8b$318.34+1.2%67.2K
ROIVROIVRoivant Sciences Ltd. Common Shares
Immunology & Autoimmune
$21.6b$28.58-0.0%773.6K
INCYINCYIncyte Genomics Inc
Rare Disease Therapeutics
$19.3b$101.58-0.8%767.3K
MRNAMRNAModerna, Inc. Common Stock
Infectious Disease & Vaccines
$18.7b$48.44+2.1%1.0M
NBIXNBIXNeurocrine Biosciences Inc
Neuroscience & CNS
$15.9b$162.99-0.5%136.7K
JAZZJAZZJazz Pharmaceuticals, Inc.
Neuroscience & CNS
$14.8b$237.04-0.6%122.8K
ASNDASNDAscendis Pharma A/S Ordinary Share
Clinical-Stage Platforms
$13.8b$205.06-2.6%80.3K
SMMTSMMTSummit Therapeutics Inc. Common Stock
Infectious Disease & Vaccines
$13.6b$14.63-1.0%989.9K
BBIOBBIOBridgeBio Pharma, Inc. Common Stock
Rare Disease Therapeutics
$13.0b$67.85+0.4%248.7K
MEDPMEDPMedpace Holdings, Inc. Common Stock
Clinical-Stage Platforms
$12.8b$459.84+1.2%31.2K
IONSIONSIonis Pharmaceuticals, Inc. Common Stock
Rare Disease Therapeutics
$12.6b$74.09-0.5%321.1K
AXSMAXSMAxsome Therapeutics, Inc
Neuroscience & CNS
$12.1b$237.66+2.3%142.0K
RGCRGCRegencell Bioscience Holdings Limited Ordinary Shares
Neuroscience & CNS
$11.8b$21.10+5.6%32.3K
RVTYRVTYRevvity, Inc.
Clinical-Stage Platforms
$11.7b$102.02+3.7%309.6K
MDGLMDGLMadrigal Pharmaceuticals, Inc. Common Stock
Metabolic & Cardiometabolic
$11.5b$477.95-1.9%46.5K
BMRNBMRNBioMarin Pharmaceuticals Inc
Rare Disease Therapeutics
$11.1b$56.49-0.5%267.4K
ARWRARWRArrowhead Research Corporation
Rare Disease Therapeutics
$11.0b$73.44+0.5%196.5K
CYTKCYTKCytokinetics Inc.
Rare Disease TherapeuticsNeuroscience & CNS
$10.4b$69.33-3.0%399.5K
ICLRICLRIcon Plc
Clinical-Stage Platforms
$10.4b$151.28+1.2%163.6K
PRAXPRAXPraxis Precision Medicines, Inc. Common Stock
Neuroscience & CNS
$9.8b$250.99-1.2%123.3K
KRYSKRYSKrystal Biotech, Inc. Common Stock
Rare Disease Therapeutics
$9.1b$304.06+1.0%44.0K
BRKRBRKRBruker Corporation
Clinical-Stage Platforms
$9.0b$57.69+2.3%528.6K
CRLCRLCharles River Laboratories International, Inc.
Clinical-Stage Platforms
$8.7b$185.23+2.1%106.0K
BIO.BBIO.BBio-Rad Laboratories, Inc. Class B
Clinical-Stage Platforms
$8.1b$306.58+0.8%2
TECHTECHBio-Techne Corp.
Clinical-Stage Platforms
$8.1b$53.34+2.6%848.0K
HALOHALOHalozyme Therapeutics, Inc.
Clinical-Stage Platforms
$7.9b$71.27-0.4%381.4K
IBRXIBRXImmunityBio, Inc. Common Stock
Immunology & Autoimmune
$7.9b$7.06+2.1%3.9M
QGENQGENQIAGEN N.V.
Clinical-Stage Platforms
$7.5b$36.67-0.0%347.5K
CORTCORTCorcept Therapeutics Inc.
Rare Disease Therapeutics
$7.5b$74.78+3.0%157.0K
PCVXPCVXVaxcyte, Inc. Common Stock
Infectious Disease & Vaccines
$7.4b$46.29-2.3%156.7K

Explore Similar Themes